This company has shut down. XinThera is no longer operating — its last tracked round was a Series B in 2021.
Explore the Startup GraveyardXinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
XinThera has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in August 2021.
XinThera's investors include OrbiMed, Foresite Capital, TTM Capital.
XinThera is headquartered in San Diego, United States.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
XinThera is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"XinThera — Funding & Investors." VCBacked, August 4, 2021, https://www.vcbacked.co/company/xinthera. Accessed September 16, 2026.
VCBacked. (2021). XinThera — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/xinthera
{{cite web |title=XinThera — Funding & Investors |url=https://www.vcbacked.co/company/xinthera |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated